Encapsulated Glioma — Trials

Encapsulated Glioma — Trials · CancerIndex

Clinical trials

Registered studies

328 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 116
Recruiting: 55
Ph III recruiting: 5
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 40.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (51)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07712757	Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma	not yet recruiting	Phase 3	140	Nuvation Bio Inc.INDUSTRY	0	Jul 17, 2026	clinicaltrials
NCT07004075	FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade Glioma Patients With BRAF Alteration	not yet recruiting	Phase 3	102	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.INDUSTRY	1	Jun 4, 2025